21st Century Cures Act BRAIN Research Through Advancing Innovative Neurotechnologies — CFDA 93.372

Cures Act BRAIN obligations at $617.1M

USAspending.gov records $617,106,978.24 in obligations under CFDA 93.372. Two hundred thirty-three awards produce that stock. A simple average is about $2.65 million per award. That average is a quotient of two packet totals, not a typical NIH research invoice and not a cost per tool developed.

The assistance-listing title is 21ST CENTURY CURES ACT - BRAIN RESEARCH THROUGH ADVANCING INNOVATIVE NEUROTECHNOLOGIES. CFDA 93.372 is the identifier. Other NIH neuroscience or Cures Act listings tagged under different CFDA numbers are not mixed into the $617.1M. Combining those codes would invent a combined brain-research total this packet does not contain.

91 recipients and 233 award rows

Ninety-one recipients share 233 awards, or about 2.6 award records per recipient on average. Splitting $617,106,978.24 evenly would assign about $6.78 million per recipient. That density is a university-and-institute pattern: a moderate organizational headcount carrying a few assistance rows each. The packet does not list the 91. Recipient count is the organizational headcount on the federal extract, not a census of labs or investigators.

Twenty-six states in the geographic count is a research-cluster map. BRAIN dollars follow investigator geography as coded, not equal shares. Place-of-performance amounts are on the program table.

Award rows are not a publication census

Among HHS research listings, 93.372 is a mid-row Cures Act file: 233 awards against 91 recipients. Award count is a weak proxy for “number of BRAIN projects” and a worse proxy for tools or papers. Recipients (91) tell you how many named organizations sit on the extract; awards (233) tell you how many assistance rows were stored.

The packet does not report publications, datasets, or technologies. Citing 233 as brains mapped would be a unit error. Keep the units straight: dollars, awards, recipients, states.

Obligations versus BRAIN outlays

The $617.1M is an obligation total from USAspending.gov. Outlays — cash paid against Cures Act BRAIN awards — are not in the packet. A research file can show a large obligation stock while draws follow a later calendar. Deobligations and upward adjustments both move the total. A remaining-balance question is an outlay question this extract does not answer.

Use CFDA 93.372 to size this 21st Century Cures Act BRAIN listing in the assistance file. Do not use it as a general NIH R01 or non-Cures neuroscience dashboard. Those series live elsewhere. This page reports the obligation book tagged 93.372.

What the 93.372 tables omit

The program hub lists award-backed obligations from USAspending.gov. It is not a publications index, not a lab directory, and not a tool catalog. Series that never appear as assistance awards will not show up in the $617,106,978.24. That omission is definitional rather than a gap in the 233 award rows.

Place-of-performance on 26 states is a coding field. Read the program page before treating those cells as a national neuroscience total. Recipient dollars, if shown on the hub, are still obligation amounts, not cash already paid to investigators.

Cures Act BRAIN’s 26-state map and 91-recipient headcount together describe a research-cluster book, not a nationwide NIH formula. A researcher comparing 93.372 with non-Cures neuroscience codes should keep CFDA numbers separate. The $617.1M stock is the USAspending obligation book for this listing only.

Where the 93.372 table lives

The program page overlays these four facts. The all-programs index ranks 93.372 among other assistance listings. Agency pages show awarding-agency rollups that may include this CFDA among other HHS listings. For 93.372 only, start on the program page.

CFDA 93.372’s 233 awards spread $617,106,978.24 across 91 recipients and 26 states. Quote award count as a record count, recipient count as the organizational headcount, and dollars as obligations from USAspending.gov. About 2.6 award records per recipient is the density story on this listing. Outlays remain a separate column. Source: USAspending.gov assistance awards.

Papers, tools, and datasets live in other NIH series. Those rows are outside $617,106,978.24 unless they share CFDA 93.372. Quote 233 as assistance records, 91 as organizational payees, and 26 as the geographic count.

Questions

How much is obligated for Cures Act BRAIN research?

USAspending.gov records $617.1M in obligations for CFDA 93.372. SpendingVault indexes 233 awards, 91 recipients, and 26 states. The figure is an obligation sum from assistance awards, not an outlay and not a publication count. CFDA 93.372’s $617,106,978.24 is the USAspending obligation stock.

How many awards does CFDA 93.372 carry?

The listing shows 233 awards against 91 recipients, or about 2.6 award records per recipient. A simple average is about $2.65 million per award. Award count is not a count of papers or tools. Recipient dollars are on the program page.

How many organizations receive 93.372 awards?

The extract lists 91 recipients. Those are organizational recipients on assistance awards tagged 93.372, not a census of labs or investigators. Geographic coding covers 26 states. The packet does not name the 91 or publish a paper count. Keep dollars, awards, recipients, and geography as separate units on the USAspending extract.

Is $617.1M already paid for BRAIN Initiative research?

Not necessarily. Obligations are commitments. Outlays are payments. CFDA 93.372’s indexed total is the obligation stock from USAspending.gov. This page does not report cash drawn, remaining balances, or tools delivered. The $617,106,978.24 on 233 awards is the obligation figure. Keep dollars, awards, recipients, and geography as separate units on the USAspending extract.